Order Article Reprints

Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou NPE. Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review. Pharmaceuticals. 2024; 17(5):568. https://doi.org/10.3390/ph17050568

Velidakis, Nikolaos, Panagiotis Stachteas, Evangelia Gkougkoudi, Christodoulos Papadopoulos, and Nikolaos P. E. Kadoglou. 2024. "Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review" Pharmaceuticals 17, no. 5: 568. https://doi.org/10.3390/ph17050568

Velidakis, N., Stachteas, P., Gkougkoudi, E., Papadopoulos, C., & Kadoglou, N. P. E. (2024). Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review. Pharmaceuticals, 17(5), 568. https://doi.org/10.3390/ph17050568